Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2018 at "Kardiologia polska"
DOI: 10.5603/kp.a2018.0056
Abstract: BACKGROUND Prevention of thromboembolic complications is a priority in patients with atrial fibrillation (AF). The use of non-vitamin K antagonist oral anticoagulants (NOACs) is more common and some patients have indications for a reduced dose.… read more here.
Keywords: atrial fibrillation; receiving reduced; reduced dose; patients receiving ... See more keywords